Meta-analysis of hypertension as a risk factor of cerebrovascular disorders in Koreans

Journal of Korean Medical Science

Volumn 16, Issue 1, 2001, Pages 2-8

  Park, Jong Ku ^a   Kim, Chun Bae ^a   Kim, Ki Soon ^b   Kang, Myung Guen ^c   Jee, Sun Ha ^d  

^a Yonsei University Wonju   (South Korea)

^b Chosun University   (South Korea)

^c Ewha Womans University   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

Cerebrovascular Disorders; Hypertension; Korea; Meta Analysis

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; HYPERTENSION; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

CEREBROVASCULAR ACCIDENT; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 0035259984     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2001.16.1.2     Document Type: Article

References (46)

1. Lee HC, Wee BA, Park OK, Kang JC, Shin YK, Lee SR, Park YH, Park WH, Park YC, Yoo WS, Lee Y, Ryoo UH, Chung MS, Chee YK, Yang IS, Kim JW, Park W, Lee HS. Changing pattern of cerebrovascular disease in Korea partially viewed through literatures. J Korean Med Assoc 1991; 34: 758-68.
2. Suh I, Jee SH, Kim IS. Changing pattern of cardiovascular diseases in Korea. Korean J Epidemiol 1993; 15: 40-6.
3. Kim IS. Mortality patterns of major causes of deaths in Korea. J Korean Med Assoc 1995; 38: 132-45.
4. National Statistical Office Republic of Korea. 1998 annual report on the cause of death statistics (based on vital registration). 1999.
5. Marmott MG, Poulter NR. Primary prevention of stroke. Lancet 1992; 339: 344-7.
6. Rhee WH, Kim JS. A review study of cerebrovascular diseases in Korea. Korean J Epidemiol 1981; 3: 1-22.
7. Park JK. Trends of the cardiovascular disease studies in Korea. Korean J Epidemiol 1993; 15: 47-55.
8. Kelly JT, Swartwout JE. Development of practice parameters by physician organization. Qual Rev Bull 1990; 16: 54-7.
9. American College of Physicians. Clinical practice guidelines. Philadelphia, Pennsylvania, 1995.
10. Browman GP, Levine MN, Mohide EA, Hayward RS, Pritchard KI, Gafni A, Laupacis A. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995; 13: 502-12.
11. Jenicek M. Meta-analysis in medicine. In: Epidemiology-The Logic of Modern Medicine. Montreal, Canada EPIMED, 1995.
12. Counsell C. Formulating questions and locating primary studies for inclusion in systemic review. Ann Intern Med 1997; 127: 380-7.
13. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systemic reviews. Ann Intern Med 1997; 127: 820-6.
14. Egger M, Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
15. Kim JS, Chung MH, Yang SJ, Yoon HS, Heo Y, Huh BY. An epidemiologic study of cerebrovascular diseases through stroke registry and case-control study on risk factors in semi-urban and rural communities. Korean J Epidemiol 1984; 6: 112-23.
16. Shin GM, Lee DK, Yi SD, Suh CK, Park YC. A study on risk factors of strokes. J Korean Neurol Assoc 1988; 6: 218-27.
17. Han SH, Lee SS. Case-control study on some risk factors of cerebrovascular diseases in rural community-matched analysis with one control per case-. Korean J Prev Med 1988; 21: 82-7.
18. Kim JS, Sunwoo IN, Kim JS. Risk factors of ischemic brain stroke in Korean diabetic patients: a retrospective study. Yonsei Med J 1989; 30: 288-93.
19. Lee HC, Wee BA, Park OK, Kang JC, Shin YK, Lee SR, Park YH, Park WH, Park YC, Lee Y, Yoo WS, Ryoo UH, Park JE, Yang IS, Kim JW, Chung MS, Chee YK, Park W, Lee HS. Risk factors for subtypes of cerebrovascular disease in Korea. Korean Circ J 1991; 21: 1081-95.
20. O KY, Byun YJ. A comparative study of the risk factors in different subtypes of ischemic cerebrovascular disease. New Med J 1992; 35: 35-44.
21. Kim JR, Hong DY, Park SH. A hospital-based case-control study on the risk factors of cerebrovascular disease. Korean J Prev Med 1995; 28: 473-86.
22. O SW, Do BW, Sun WS, Song YM, Yoo TW. Risk factors of cerebral infarction among Koreans. J Korean Acad Fam Med 1996; 17: 91-101.
23. Rhee KH, Choi SI, Lee SO, Lim CS, Park TS, Baek HS. Relationship between carotid artery plaque measured by ultrasound and cerebral infarction in patients with non-insulin dependent diabetes. J Korean Diab Assoc 1997; 21: 469-75.
24. Song HH. Meta-Analysis. Seoul: Chung Moon Kak Press, 1998.
25. Jee SH, He J, Whelton PK, Suh I, Klag MJ. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 1999; 33: 647-52.
26. Kim WO, Kil HK, Koh SO, Kim JI. Effects of general and locoregional anesthesia on reproductive outcome for in vitro fertilization: a meta-analysis. J Korean Med Sci 2000; 15: 68-72.
27. Oh HS, Seo WS. Inter-relationships between arteriosclerotic risk factors: a meta-analysis. Yonsei Med J 2000; 41: 450-8.
28. Cook DJ, Sackett DL, Spitzer WO. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on meta-analysis. J Clin Epidemiol 1995; 48: 167-71.
29. Shapiro S. Meta-analysis/Shmeta-analysis. Am J Epidemiol 1994; 9: 771-8.
30. Mosteller F, Colditz GA. Understanding research synthesis (meta-analysis). Annu Rev Public Health 1996; 17: 1-23.
31. Bailar JC III. The practice of meta-analysis. J Clin Epidemiol 1995; 48: 149-57.
32. Stroup DF, Thacker SB, Olson CM, Glass RM. Characteristics of meta-analyses submitted to a medical journal. From: International Congress on Biomedical Peer Review and Global Communications; September 17-21, 1997; Prague, Czech Republic.
33. Huston P, Naylor CD. Health services research: reporting on studies using secondary data sources. CMAJ 1996; 155: 1697-709.
34. Egger M, Scheider M, Davey-Smith G. Meta-analysis. BMJ 1998; 316: 140-4.
35. Yoo KY. Categorical data analysis for medical science & public health: linear logit analysis. Seoul National University Press, 1995.
36. Brownson RC, Remington PI, Davis JR, eds. Chronic disease epidemiology and control. Washington American Public Health Association, 1993.
37. He J, Michael JK, Zhengai Wu, Whelton PK. Stroke in the People's Republic of China II. Meta-analysis of hypertension and risk of stroke. Stroke 1995; 26: 2228-32.
38. Stokes J III, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease: the Framingham Study-30 years of follow-up. Hypertension 1989; 13(Suppl I): 113-8.
39. Fiebach NH, Hebert PR, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. A prospective study of high blood pressure and cardiovascular disease in women. Am J Epidemiol 1989; 130: 646-54.
40. Shaper AG, Phillips AN, Pocock SJ, Walker M, Macfarlane PW. Risk factors for stroke in middle aged British men. BMJ 1991; 302: 1111-5.
41. Jamrozik K, Broadhurst RJ, Anderson CS, Stewart-Wynne EG. The role of lifestyle factors in the etiology of stroke: a population-based case-control study in Perth, Western Australia. Stroke 1994; 25: 51-9.
42. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 2008-12.
43. WHO. Hypertension control. Geneva, World Health Organization, 1996.
44. Greenland S. Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol 1994; 140: 290-6.
45. Emerson JD, Burdick E, Hoaglin DC, Mosteller F, Chalmers TC. An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. Control Clin Trials 1990; 11: 339-52.
46. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282: 1054-60.